Tokyo Tape
Sign in
← Em Systems

Quarterly report · Q2

4820.TEDINET S100OY0R
Period2022-01-01 → 2022-06-30
Filed2022-08-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥8.2bn2022-01-01 → 2022-06-30Cons.Net sales
Revenue¥14.4bn2021-01-01 → 2021-12-31Cons.Net sales (5-year summary)
Revenue¥6.7bn2021-01-01 → 2021-06-30Cons.Net sales
Operating income¥1.4bn2022-01-01 → 2022-06-30Cons.Operating income
Operating income¥582m2021-01-01 → 2021-06-30Cons.Operating income
Ordinary income¥1.6bn2022-01-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥2.6bn2021-01-01 → 2021-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.0bn2021-01-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥1.6bn2022-01-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥1.0bn2021-01-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥1.1bn2022-01-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.8bn2021-01-01 → 2021-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥687m2021-01-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥1.1bn2022-01-01 → 2022-06-30Cons.Profit loss
Net income¥679m2021-01-01 → 2021-06-30Cons.Profit loss
Total assets¥24.8bnat 2022-06-30Cons.Assets
Total assets¥24.8bnat 2021-12-31Cons.Assets
Total assets¥23.6bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥5.7bnat 2022-06-30Cons.Liabilities
Total liabilities¥6.0bnat 2021-12-31Cons.Liabilities
Net assets / equity¥19.1bnat 2022-06-30Cons.Net assets
Net assets / equity¥18.8bnat 2021-12-31Cons.Net assets
Net assets / equity¥17.9bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥8.4bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥8.3bnat 2021-12-31Cons.Cash and deposits
Cash & equivalents¥8.4bnat 2022-06-30Cons.Cash and cash equivalents
Cash & equivalents¥8.3bnat 2021-12-31Cons.Cash and cash equivalents
Cash & equivalents¥7.3bnat 2021-06-30Cons.Cash and cash equivalents
Cash & equivalents¥8.0bnat 2020-12-31dCons.Cash and cash equivalents
Operating cash flow¥1.3bn2022-01-01 → 2022-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥1.7bn2021-01-01 → 2021-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥760m2021-01-01 → 2021-06-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥295m2022-01-01 → 2022-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥544m2021-01-01 → 2021-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥831m2021-01-01 → 2021-06-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥876m2022-01-01 → 2022-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥693m2021-01-01 → 2021-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥400m2021-01-01 → 2021-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥15.352022-01-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥7.422022-04-01 → 2022-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥25.722021-01-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥9.682021-01-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥5.462021-04-01 → 2021-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥15.312022-01-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥25.642021-01-01 → 2021-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥9.652021-01-01 → 2021-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio76.6%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio75.5%at 2021-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio75.4%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 42
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-01-01 → 2022-06-30−¥24m
Reconciling Itemsreconcilingrevenue intersegment2022-01-01 → 2022-06-30−¥24m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-06-30¥15m
jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥268m
jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥268m
jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segmentsegment profit2022-01-01 → 2022-06-30¥55m
jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥1.1bn
jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥1.1bn
jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentsegment profit2022-01-01 → 2022-06-30−¥184m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥347m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥328m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentrevenue intersegment2022-01-01 → 2022-06-30¥19m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentsegment profit2022-01-01 → 2022-06-30−¥22m
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥6.5bn
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥6.5bn
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue intersegment2022-01-01 → 2022-06-30¥5m
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentsegment profit2022-01-01 → 2022-06-30¥1.5bn
—segment totalrevenue2022-01-01 → 2022-06-30¥8.2bn
—segment totalrevenue external2022-01-01 → 2022-06-30¥8.2bn
—segment totalrevenue intersegment2022-01-01 → 2022-06-30¥24m
—segment totalsegment profit2022-01-01 → 2022-06-30¥1.3bn
Reconciling Itemsreconcilingrevenue2021-01-01 → 2021-06-30−¥6m
Reconciling Itemsreconcilingrevenue intersegment2021-01-01 → 2021-06-30−¥6m
Reconciling Itemsreconcilingsegment profit2021-01-01 → 2021-06-30¥15m
jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue2021-01-01 → 2021-06-30¥303m
jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue external2021-01-01 → 2021-06-30¥303m
jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segmentsegment profit2021-01-01 → 2021-06-30¥4m
jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue2021-01-01 → 2021-06-30¥920m
jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue external2021-01-01 → 2021-06-30¥920m
jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentsegment profit2021-01-01 → 2021-06-30−¥16m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentrevenue2021-01-01 → 2021-06-30¥356m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentrevenue external2021-01-01 → 2021-06-30¥351m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentrevenue intersegment2021-01-01 → 2021-06-30¥5m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentsegment profit2021-01-01 → 2021-06-30−¥11m
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue2021-01-01 → 2021-06-30¥5.1bn
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue external2021-01-01 → 2021-06-30¥5.1bn
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue intersegment2021-01-01 → 2021-06-30¥1m
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentsegment profit2021-01-01 → 2021-06-30¥591m
—segment totalrevenue2021-01-01 → 2021-06-30¥6.7bn
—segment totalrevenue external2021-01-01 → 2021-06-30¥6.7bn
—segment totalrevenue intersegment2021-01-01 → 2021-06-30¥6m
—segment totalsegment profit2021-01-01 → 2021-06-30¥567m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 537
ItemContextValueUnit
Net cash provided by used in financing activitiesPrior1YTDDuration-400000000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration-876000000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YTDDuration19000000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYTDDuration43000000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration-451000000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration129000000JPY
Cash and cash equivalentsPrior2YearInstant7982000000JPY
Cash and cash equivalentsPrior1YearInstant8289000000JPY
Decrease in cash and cash equivalents resulting from exclusion of subsidiaries from consolidation ccePrior1YTDDuration-202000000JPY
Decrease in cash and cash equivalents resulting from exclusion of subsidiaries from consolidation cceCurrentYTDDuration－JPY
Cash and cash equivalentsPrior1QuarterInstant7329000000JPY
Cash and cash equivalentsCurrentQuarterInstant8418000000JPY
Salaries and allowances sgaPrior1YTDDuration1050000000JPY
Salaries and allowances sgaCurrentYTDDuration1215000000JPY
Provision for bonuses sgaPrior1YTDDuration241000000JPY
Provision for bonuses sgaCurrentYTDDuration222000000JPY
Retirement benefit expenses sgaPrior1YTDDuration53000000JPY
Retirement benefit expenses sgaCurrentYTDDuration54000000JPY
Provision for product warranties sgaPrior1YTDDuration-10000000JPY
Provision for product warranties sgaCurrentYTDDuration1000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E05155-000PharmacyReceiptComputerAndRelatedBusinessReportableSegmentsMember5097000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E05155-000MedicineReceiptComputerAndRelatedBusinessReportableSegmentsMember920000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E05155-000CareWelfareITSystemsBusinessReportableSegmentsMember303000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E05155-000OtherBusinessReportableSegmentsMember351000000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember6672000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration6672000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E05155-000PharmacyReceiptComputerAndRelatedBusinessReportableSegmentsMember1000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E05155-000MedicineReceiptComputerAndRelatedBusinessReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E05155-000CareWelfareITSystemsBusinessReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E05155-000OtherBusinessReportableSegmentsMember5000000JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember6000000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-6000000JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E05155-000PharmacyReceiptComputerAndRelatedBusinessReportableSegmentsMember5098000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E05155-000MedicineReceiptComputerAndRelatedBusinessReportableSegmentsMember920000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E05155-000CareWelfareITSystemsBusinessReportableSegmentsMember303000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E05155-000OtherBusinessReportableSegmentsMember356000000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember6678000000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-6000000JPY
Net salesPrior1YTDDuration6672000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E05155-000PharmacyReceiptComputerAndRelatedBusinessReportableSegmentsMember591000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E05155-000MedicineReceiptComputerAndRelatedBusinessReportableSegmentsMember-16000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E05155-000CareWelfareITSystemsBusinessReportableSegmentsMember4000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E05155-000OtherBusinessReportableSegmentsMember-11000000JPY
Operating incomePrior1YTDDuration_ReportableSegmentsMember567000000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember15000000JPY
Operating incomePrior1YTDDuration582000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E05155-000PharmacyReceiptComputerAndRelatedBusinessReportableSegmentsMember6494000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E05155-000MedicineReceiptComputerAndRelatedBusinessReportableSegmentsMember1072000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2021-12-31pass
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2021-12-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-01-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2021-01-01/2021-06-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-01-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-01-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2021-12-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass